Corcept Therapeutics Incorporated (CORT)

NASDAQ: CORT · Real-Time Price · USD

122.25

+1.20 (0.99%)

At close: Aug 21, 2026, 4:00 PM EDT

120.00

-2.25 (-1.84%)

After-hours: Aug 21, 2026, 6:28 PM EDT

Corcept Therapeutics Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	830.81	761.41	675.04	482.38	401.86	365.98
Revenue Growth	16.02%	12.79%	39.94%	20.04%	9.80%	3.42%
Gross Profit	816.73	748.43	664.16	475.89	396.47	360.7
Operating Income	6.41	44.8	136.95	107.28	112.63	124.48
Net Income	54.27	98.17	139.73	105.5	101.29	112.51
Earnings Per Share	0.45	0.82	1.23	0.94	0.87	0.89
EPS Growth	-59.30%	-33.33%	30.85%	8.05%	-2.25%	4.71%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	544.65	532.42	603.17	425.4	436.62	335.81
Total Debt	9.42	6.11	6.94	0.15	1.14	0.53
Net Cash (Debt)	535.23	526.32	596.23	425.25	435.48	335.29
Net Cash Growth	5.28%	-11.73%	40.21%	-2.35%	29.88%	-29.32%
Net Cash Per Share	4.53	4.39	5.25	3.81	3.76	2.66

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	109.7	142	198.3	126.68	120.32	167.89
Capital Expenditures	-2.78	-0.21	-2.17	-0.14	-0.41	-0.47
Free Cash Flow	106.92	141.79	196.12	126.54	119.91	167.42
Free Cash Flow Growth	-40.76%	-27.71%	54.99%	5.53%	-28.38%	11.07%

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	98.30%	98.30%	98.39%	98.66%	98.66%	98.56%
Operating Margin	0.77%	5.88%	20.29%	22.24%	28.03%	34.01%
Pretax Margin	3.17%	8.73%	23.92%	25.82%	28.91%	34.16%
Profit Margin	6.53%	12.89%	20.70%	21.87%	25.20%	30.74%
FCF Margin	12.87%	18.62%	29.05%	26.23%	29.84%	45.75%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 21, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	269.48	37.29	37.78	31.74	21.59	18.64
Forward PE	30.64	55.53	32.11	32.61	19.95	21.01
P/FCF Ratio	122.43	25.82	26.92	26.46	18.23	12.53
PS Ratio	15.76	4.81	7.82	6.94	5.44	5.73